Patent assignee · CH · COMPANY

ADC THERAPEUTICS SA

22Patents
22Active
22Granted
48Portfolio score

Filing activity: Nov 3, 2009 → Mar 18, 2022 · 1 expiring within 5 years

Most-cited patents

PatentTitleAreaCited byStatus
US9931414B2 Pyrrolobenzodiazepine-antibody conjugates Chemistry; Metallurgy 7 Active
US9931415B2 Pyrrolobenzodiazepine-antibody conjugates Chemistry; Metallurgy 6 Active
US10017580B2 Humanized anti-Tn-MUC1 antibodies and their conjugates Emerging Cross-Sectional Technologies 6 Active
US9919056B2 Pyrrolobenzodiazepine-anti-CD22 antibody conjugates Emerging Cross-Sectional Technologies 6 Active
US10544223B2 Combination therapy with an anti-axl antibody-drug conjugate Chemistry; Metallurgy 4 Active
US10780096B2 Pyrrolobenzodiazepine-antibody conjugates Emerging Cross-Sectional Technologies 4 Active
US9828426B2 Antibodies against kidney associated antigen 1 and antigen binding fragments thereof Chemistry; Metallurgy 2 Active
US11160872B2 Pyrrolobenzodiazepine-antibody conjugates Chemistry; Metallurgy 2 Active
US11318211B2 Dosage regimes for the administration of an anti-CD19 ADC Chemistry; Metallurgy 1 Active
US10722594B2 Pyrrolobenzodiazepine-anti-CD22 antibody conjugates Emerging Cross-Sectional Technologies 1 Active
US10799596B2 Pyrrolobenzodiazepine-antibody conjugates Chemistry; Metallurgy 1 Active
US11596696B2 Combination therapy with an anti-CD25 antibody-drug conjugate Chemistry; Metallurgy 1 Active
US11976122B2 Anti-IL13Rα2 antibodies Chemistry; Metallurgy 0 Active
US10597450B2 Antibodies against kidney associated antigen 1 and antigen binding fragments thereof Chemistry; Metallurgy 0 Active
US11938192B2 Dosage regimes for the administration of an anti-CD19 ADC Chemistry; Metallurgy 0 Active
US9855291B2 Anti-kidney associated antigen 1 (KAAG1) antibodies Chemistry; Metallurgy 0 Active
US11702473B2 Site-specific antibody-drug conjugates Emerging Cross-Sectional Technologies 0 Active
US11690918B2 Pyrrolobenzodiazepine-anti-CD22 antibody conjugates Emerging Cross-Sectional Technologies 0 Active
US11084872B2 Method for treating breast cancer Chemistry; Metallurgy 0 Active
US11813335B2 Pyrrolobenzodiazepine-antibody conjugates Chemistry; Metallurgy 0 Active
US11426467B2 Dosage regimes for the administration of an anti-CD25 ADC Human Necessities 0 Active
US11384098B2 Pyrrolobenzodiazepine-antibody conjugates Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.